The Association for the Cannabinoid Industry (ACI) is a membership organisation for businesses committed to nurturing a safe, legal and flourishing commercial cannabis extract market in the UK and Europe.
Our vision is to create an innovative and ethical sector with the highest standards of product quality, consumer satisfaction and regulatory compliance. All our members sign up to our quality charter.
We deliver vital stewardship for this emerging sector through constructive engagement with key stakeholders and thought leaders. To find out what we’ve achieved see our list of milestones.
Our team of scientific, regulatory and industry leaders provide expert support and guidance to our members.
ACI in the Media
Now that the UK regulates CBD as a natural supplement, industry groups are calling on the government to reform contradictory hemp laws
Consumer demand for CBD products has soared during lockdown, according to the Association for the Cannabinoid Industry (ACI), which estimates the sector will generate £690 million in annual sales this year, above a previous forecast of £526 million.
“We were expecting it to grow,” Steve Moore, co-founder and strategic counsel to the CMC and ACI, tells NutritionInsight. “It was always likely that when levels of stress and anxiety would rise with the various lockdowns we’ve had here in the UK, the pandemic would increase demand.”
Sky News reports on our new report and how sales of consumer cannabis products have undergone an “accidental” boom during the pandemic.
Research from two industry pressure groups reveals the UK cannabinoid (CBD) industry was worth £690 million in the 12 months to the end of April – up almost a third year on year.
The UK CBD market could generate £690 million (€800 million) in 2021 sales. More government intervention and investment is needed “to ensure that the UK optimizes ‘Britain’s quiet cannabis revolution’,” ACI’s report urges.
The sector is now estimated to generate £690 million in annual sales for 2021. This figure surpasses predictions made in the seminal market sizing study undertaken by the CMC in 2019 which estimated the market would be worth £526 million in 2021.
The report argues that the market represents a key growth sector for the UK and it is time for the government to adopt a proactive strategy to seize opportunities in the cannabinoids sector. It makes 20 recommendations to stimulate post-Covid economic growth.
The UK CBD sector is predicted to generate £690 million in annual sales in 2021, according to a new report from two leading industry bodies.
The report from the Centre for Medicinal Cannabis (CMC) and the Association for the Cannabinoid Industry (ACI) was published this morning.